Strata Critical Medical (SRTA) Long-Term Investments (2019 - 2023)

Strata Critical Medical (SRTA) has 5 years of Long-Term Investments data on file, last reported at $390000.0 in Q3 2023.

• Long-Term Investments for Q3 2023 came in at $390000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2023 was $390000.0 (changed 0.0% YoY), and the FY2022 annual result was $390000.0, up 95.0% from the prior year.
• Long-Term Investments was little changed at $390000.0 in Q3 2023 per SRTA's latest filing, from $390000.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $277.2 million in Q2 2020 and troughed at $200000.0 in Q3 2020.
• A 5-year average of $97.8 million and a median of $390000.0 in 2022 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2021 and 2022: Long-Term Investments sank 99.93% in 2021, then soared 95.0% in 2022.
• A 5-year view of Long-Term Investments shows it stood at $276.3 million in 2019, then climbed by 0.25% to $276.9 million in 2020, then sank by 99.93% to $200000.0 in 2021, then soared by 95.0% to $390000.0 in 2022, then changed by 0.0% to $390000.0 in 2023.
• Business Quant data shows SRTA's Long-Term Investments at $390000.0 in Q3 2023, $390000.0 in Q2 2023, and $390000.0 in Q1 2023.